Despite a patient's death, deemed unrelated to the Beam-101 treatment, the company's shares saw a slight decline. JPMorgan and Stifel maintained their Overweight and Buy ratings on Beam Therapeutics, ...
The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Capture valuable insights into Beam Therapeutics's market standing by ...
Naturally, after enlisting other Japanese designers like noir kei ninomiya and POTR (Porter Yoshida & co‘s sub-label) to reimagine the model, Reebok has called in BEAMS to put its spin on the ...
A bridge that is rated in “poor” condition is scheduled ... with trucks accounting for 17% of that traffic. The bridge deck has deteriorated and has developed structural deficiencies, state ...